← back to search

Paul J. Catalano

Harvard University · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Brain Metastases and Treatment, Cancer Immunotherapy and Biomarkers, and Renal cell carcinoma treatment.
h-index
76
citations
26,554
works
436
NIH funding
primary concept
Medicine
email

Recent publications

Large language models to identify social determinants of health in electronic health records
npj Digital Medicine 2024cited by 243position: middledoi
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
Journal for ImmunoTherapy of Cancer 2023cited by 30position: middledoi
Abstract OT1-12-02: Preliminary report of the PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer
Cancer Research 2023cited by 14position: middledoi
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
Journal of Clinical Oncology 2022cited by 281position: middledoi
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis
Scientific Reports 2022cited by 20position: middledoi
Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142.
Journal of Clinical Oncology 2022cited by 13position: middledoi
Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced renal cell carcinoma (RCC) (HCRN GU16-260).
Journal of Clinical Oncology 2020cited by 56position: middledoi
Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong
Blood Advances 2020cited by 16position: middledoi
Effects of biophilic indoor environment on stress and anxiety recovery: A between-subjects experiment in virtual reality
Environment International 2019cited by 405position: middledoi
Effects of biophilic interventions in office on stress reaction and cognitive function: A randomized crossover study in virtual reality
Indoor Air 2019cited by 239position: middledoi
Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases
JAMA Oncology 2019cited by 88position: middledoi
Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non–Small Cell Lung Cancer
JAMA Oncology 2018cited by 587position: middledoi
Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation
JAMA Oncology 2018cited by 304position: middledoi
A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
Journal of Clinical Oncology 2018cited by 169position: middledoi
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
Neuro-Oncology 2017cited by 823position: middledoi
Brain Metastases in Newly Diagnosed Breast Cancer
JAMA Oncology 2017cited by 304position: middledoi
Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques
Radiotherapy and Oncology 2017cited by 23position: middledoi
Outcomes with image-based interstitial brachytherapy for vaginal cancer
Radiotherapy and Oncology 2016cited by 42position: middledoi
A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
Journal of Clinical Oncology 2015cited by 114position: middledoi
Impact of the New U.S. Department of Agriculture School Meal Standards on Food Selection, Consumption, and Waste
American Journal of Preventive Medicine 2014cited by 243position: middledoi
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
JNCI Journal of the National Cancer Institute 2013cited by 90position: middledoi
Enrollment of Patients With Lung and Colorectal Cancers Onto Clinical Trials
Journal of Oncology Practice 2013cited by 63position: middledoi
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
New England Journal of Medicine 2012cited by 1,147position: middledoi
Dietary intake and dietary quality of low-income adults in the Supplemental Nutrition Assistance Program
American Journal of Clinical Nutrition 2012cited by 258position: middledoi
Representativeness of Participants in the Cancer Care Outcomes Research and Surveillance Consortium Relative to the Surveillance, Epidemiology, and End Results Program
Medical Care 2012cited by 81position: firstdoi
Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles
Biomaterials 2012cited by 45position: middledoi
Cytoreductive Surgery and Intraoperative Administration of Paclitaxel-loaded Expansile Nanoparticles Delay Tumor Recurrence in Ovarian Carcinoma
Annals of Surgical Oncology 2012cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel Cagney · Royal College of Surgeons in Ireland5 papers (2017–2019)Brian M. Alexander · Fox Chase Cancer Center5 papers (2017–2019)Ayal A. Aizer · Harvard University5 papers (2017–2019)Peter J. O’Dwyer · ECOG-ACRIN Cancer Research Group4 papers (2015–2022)George A. Fisher · Stanford Medicine4 papers (2015–2022)Allison Martin · Albert Einstein College of Medicine4 papers (2017–2018)Pamela L. Kunz · Yale Cancer Center3 papers (2015–2022)Teri A. Longacre · Stanford University3 papers (2015–2022)Yu‐Hui Chen · Fujian Medical University3 papers (2017–2023)Jane C. Weeks · King Edward Memorial Hospital3 papers (2012–2013)Al B. Benson · Indo-American Center3 papers (2015–2022)Diane Reidy‐Lagunes · Kettering University3 papers (2015–2022)Nancy U. Lin · San Francisco Art Institute3 papers (2017–2018)Halla Nimeiri · Tempus Labs (United States)3 papers (2015–2022)Jonathan Strosberg · Moffitt Cancer Center3 papers (2015–2022)Robert Alter · Hackensack University Medical Center2 papers (2020–2023) · 2 papers (2017–2023)Jeffrey A. Sosman · Northwestern University2 papers (2020–2023)Edmond L. Schmulbach · Colorado Permanente Medical Group2 papers (2018–2022)Amanda J. Redig · Io Therapeutics (United States)2 papers (2017–2018)